Sheldon Koenig is the President and CEO of Esperion Therapeutics, a company that developed the only U.S. Based in Ann Arbor, Michigan.
Sheldon Koenig is the President and CEO of Esperion Therapeutics, a company that developed the only U.S. FDA-approved oral, once-daily, non-statin medicine for cardiovascular disease prevention in patients with elevated LDL cholesterol. He joined Esperion in a leadership role after the company achieved success with its Clear Outcomes study in 2023.
Full founder directory · Investor directory · Company funding database · Fundraising library